An SOD1 deficiency aggravates proteasome inhibitor bortezomib-induced testicular damage in mice

Takujiro Homma1, Junichi Fujii1

  • 1Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Yamagata University, 2-2-2 Iidanishi, Yamagata 990-9585, Japan.

Insights

Proteasome inhibitor bortezomib causes severe testicular damage in SOD1-knockout mice by increasing oxidative stress and impairing proteasome function. This highlights the critical role of SOD1 in mitigating proteasome dysfunction and preventing toxicity.

Area of Science:

  • Biochemistry
  • Toxicology
  • Cell Biology

Background:

  • Proteasomes are crucial for cellular homeostasis, degrading damaged proteins.
  • Proteasome inhibitors like bortezomib can cause testicular toxicity.
  • Oxidative stress is implicated in various cellular dysfunctions.

Purpose of the Study:

  • To investigate the role of oxidative stress in bortezomib-induced testicular toxicity.
  • To examine the impact of bortezomib on proteasome function in SOD1-knockout mice.

Main Methods:

  • Treatment of SOD1-knockout (KO) and wild-type (WT) mice with bortezomib (BTZ).
  • Assessment of superoxide production, cell death, protein aggregation (ubiquitinated proteins, p62), and proteasome activity in testicular tissues.
  • Comparison of BTZ effects between SOD1-KO and WT mice.

Main Results:

  • BTZ significantly increased superoxide production and cell death in SOD1-KO mice testes compared to WT mice.
  • Accumulation and aggregation of ubiquitinated proteins and p62 were observed in BTZ-treated SOD1-KO mice.
  • Proteasome proteolytic activity was significantly reduced in BTZ-treated SOD1-KO mice testes.

Conclusions:

  • A deficiency in SOD1 exacerbates bortezomib-induced oxidative stress.
  • Combined oxidative stress and proteasome inhibition accelerate proteasome impairment.
  • This leads to severe testicular damage in SOD1-knockout mice.

Related Concept Videos

The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.1K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.7K
The Proteasome02:18

The Proteasome

4.5K
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
1.7K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
626